Cargando…

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function

OBJECTIVE: To investigate the association between inflammation and selective echocardiographic parameters (EP) characteristic for ventricular hypertrophy in cross-sectional and longitudinal population-based analyses. METHODS: Baseline (711 men, 659 women: 45–83 years) and 4-year follow-up data (622...

Descripción completa

Detalles Bibliográficos
Autores principales: Medenwald, D, Dietz, S, Tiller, D, Kluttig, A, Greiser, KH, Loppnow, H, Thiery, J, Nuding, S, Russ, M, Fahrig, A, Haerting, J, Werdan, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189296/
https://www.ncbi.nlm.nih.gov/pubmed/25332774
http://dx.doi.org/10.1136/openhrt-2013-000004
_version_ 1782338344087191552
author Medenwald, D
Dietz, S
Tiller, D
Kluttig, A
Greiser, KH
Loppnow, H
Thiery, J
Nuding, S
Russ, M
Fahrig, A
Haerting, J
Werdan, K
author_facet Medenwald, D
Dietz, S
Tiller, D
Kluttig, A
Greiser, KH
Loppnow, H
Thiery, J
Nuding, S
Russ, M
Fahrig, A
Haerting, J
Werdan, K
author_sort Medenwald, D
collection PubMed
description OBJECTIVE: To investigate the association between inflammation and selective echocardiographic parameters (EP) characteristic for ventricular hypertrophy in cross-sectional and longitudinal population-based analyses. METHODS: Baseline (711 men, 659 women: 45–83 years) and 4-year follow-up data (622 men, 540 women) of the prospective, population-based CARdio-vascular disease, Living and Ageing in Halle (CARLA)study after exclusion of participants with cardiacvascular diseases were analysed. Inflammation parameters: soluble tumour necrosis factor receptor 1 (sTNF-R1), high-sensitivity C reactive protein (hsCRP) and interleukin 6 (IL-6). EPs: left ventricular mass (LVM), left atrial systolic dimension (LADS), interventricular septum diameter (IVSD), posterior wall dimension (PWD), left ventricular diastolic diameter (LVDD), ejection fraction according to Teichholz (EF). For the longitudinal analyses baseline to follow-up differences were considered. Effect sizes were determined by using multiple linear regression and mixed models. Missing values were replaced by means of multiple imputations. RESULTS: Men had higher sTNF-R1 levels; means of hsCRP and IL-6 were similar in men and women. In multiple regression models, sTNF-R1 was associated with LADS (1.4 mm/1000 pg/mL sTNF-R1, 95% CI 0.6 to 2.1) in men. Respecting confounder hsCRP was associated with LVM (5.2 g/10 mg/L hsCRP, 95% CI 1.6 to 8.8), IVSD (0.2 mm/10 mg/L hsCRP, 95% CI 0 to 0.3) and PWD (0.2 mm/10 mg/L hsCRP, 95% CI 0.1 to 0.3) in women, while there were no relevant effects in analysis of IL-6 in both sexes. The baseline to follow-up change in EPs was not relevantly associated with sTNF-R1, hsCRP or IL-6. CONCLUSIONS: STNF-R1, hsCRP and IL-6 were inadequate predictors for structural changes of the heart at follow-up, while weak cross-sectional associations are restricted to certain EPs and depend on sex.
format Online
Article
Text
id pubmed-4189296
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41892962014-10-20 Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function Medenwald, D Dietz, S Tiller, D Kluttig, A Greiser, KH Loppnow, H Thiery, J Nuding, S Russ, M Fahrig, A Haerting, J Werdan, K Open Heart Heart Failure and Cardiomyopathies OBJECTIVE: To investigate the association between inflammation and selective echocardiographic parameters (EP) characteristic for ventricular hypertrophy in cross-sectional and longitudinal population-based analyses. METHODS: Baseline (711 men, 659 women: 45–83 years) and 4-year follow-up data (622 men, 540 women) of the prospective, population-based CARdio-vascular disease, Living and Ageing in Halle (CARLA)study after exclusion of participants with cardiacvascular diseases were analysed. Inflammation parameters: soluble tumour necrosis factor receptor 1 (sTNF-R1), high-sensitivity C reactive protein (hsCRP) and interleukin 6 (IL-6). EPs: left ventricular mass (LVM), left atrial systolic dimension (LADS), interventricular septum diameter (IVSD), posterior wall dimension (PWD), left ventricular diastolic diameter (LVDD), ejection fraction according to Teichholz (EF). For the longitudinal analyses baseline to follow-up differences were considered. Effect sizes were determined by using multiple linear regression and mixed models. Missing values were replaced by means of multiple imputations. RESULTS: Men had higher sTNF-R1 levels; means of hsCRP and IL-6 were similar in men and women. In multiple regression models, sTNF-R1 was associated with LADS (1.4 mm/1000 pg/mL sTNF-R1, 95% CI 0.6 to 2.1) in men. Respecting confounder hsCRP was associated with LVM (5.2 g/10 mg/L hsCRP, 95% CI 1.6 to 8.8), IVSD (0.2 mm/10 mg/L hsCRP, 95% CI 0 to 0.3) and PWD (0.2 mm/10 mg/L hsCRP, 95% CI 0.1 to 0.3) in women, while there were no relevant effects in analysis of IL-6 in both sexes. The baseline to follow-up change in EPs was not relevantly associated with sTNF-R1, hsCRP or IL-6. CONCLUSIONS: STNF-R1, hsCRP and IL-6 were inadequate predictors for structural changes of the heart at follow-up, while weak cross-sectional associations are restricted to certain EPs and depend on sex. BMJ Publishing Group 2014-02-08 /pmc/articles/PMC4189296/ /pubmed/25332774 http://dx.doi.org/10.1136/openhrt-2013-000004 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Heart Failure and Cardiomyopathies
Medenwald, D
Dietz, S
Tiller, D
Kluttig, A
Greiser, KH
Loppnow, H
Thiery, J
Nuding, S
Russ, M
Fahrig, A
Haerting, J
Werdan, K
Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
title Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
title_full Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
title_fullStr Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
title_full_unstemmed Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
title_short Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
title_sort inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
topic Heart Failure and Cardiomyopathies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189296/
https://www.ncbi.nlm.nih.gov/pubmed/25332774
http://dx.doi.org/10.1136/openhrt-2013-000004
work_keys_str_mv AT medenwaldd inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT dietzs inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT tillerd inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT kluttiga inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT greiserkh inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT loppnowh inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT thieryj inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT nudings inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT russm inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT fahriga inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT haertingj inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction
AT werdank inflammationandechocardiographicparametersofventricularhypertrophyinacohortwithpreservedcardiacfunction